Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Ketamine vs. Methohexital Anesthesia for Improvement of Major Depressive Disorder in Electroconvulsive Therapy


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT02752724

Organisation Name: VA Puget Sound Health Care System

Overal Status: Completed

Start Date: March 2016

Last Update: June 6, 2018

Lead Sponsor: VA Puget Sound Health Care System

Brief Summary: The purpose of this prospective randomized clinical trial is to determine if patients receiving ketamine as a part of general anesthesia during electroconvulsive therapy (ECT) rather than standard of care will have improvement in symptoms of depression after a course of ECT treatments. The investigators hypothesize that utilization of ketamine for induction of general anesthesia during ECT treatments will improve symptoms of depression better than standard care.

This study is ONLY open to patients eligible to receive healthcare services through the Department of Veterans Affairs at the VA Puget Sound, which means service in the active military, naval or air service or separation under any condition other than dishonorable. Qualifications for VA health care benefits can be found at va.gov.

Conditions:
  • Major Depressive Disorder


Total execution time in seconds: 0.40908813476562